BOXED WARNING Suicidality — antidepressants increase risk of suicidal thinking/behavior in children, adolescents, and young adults; not approved for pediatric use.
FDA dosing
Population
Start
Target
Max
Depression — outpatients
Adults
75 mg/day
150 mg/day
200 mg/day
Depression — hospitalized
Adults
100–150 mg/day
200 mg/day
250–300 mg/day
Depression — maintenance
Adults
75–150 mg/day
Depression
Adolescent/Geriatric
25–50 mg/day (as imipramine HCl tablets)
up to 100 mg/day
100 mg/day
Titration Hospitalized: if no response after 2 weeks, may increase to 250–300 mg/day
Renal Undefined
Hepatic Undefined
Instructions
Total daily dose may be given once daily at bedtime; divided dosing if needed
At least 14 days between an MAOI and imipramine (both directions)
Following remission, gradually decrease the dose
Antidepressant effect may take 1–3 weeks
Contraindications
MAOIs (concurrently or within 14 days) due to risk of serotonin syndrome
Acute recovery period after myocardial infarction
Cautions
Clinical worsening and suicide risk
Serotonin syndrome with serotonergic drugs (linezolid, IV methylene blue)